欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/2083/002
药品名称
Gabapentin Orion
活性成分
Gabapentin 400.0 mg
剂型
Capsule, hard
上市许可持有人
Orion Corporation Orionintie 1 02200 Espoo Finland
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Latvia (LV)
Lithuania (LT)
Estonia (EE)
Hungary (HU)
Gabapentin Orion 400mg
Finland (FI)
许可日期
2017/11/30
最近更新日期
2024/11/25
药物ATC编码
N03AX12 gabapentin
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final PL
|
Common PIL clean Gabapentin Orion 300 400mg caps DCP 130319
Date of last change:2024/09/06
Final SPC
|
Common SPC clean Gabapentin Orion 300 400mg caps DCP 130319
Date of last change:2024/09/06
Final Labelling
|
Final labelling _ Gabapentin Orion 300 400mg caps Label 220617
Date of last change:2024/09/06
PubAR
|
PAR Gabapentin Orion hard capsules 300 mg and 400 mg
Date of last change:2024/09/06
PubAR Summary
|
Summary PAR Gabapentin Orion hard capsules 300 mg and 400 mg
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase